ArticleJournal of community genetics2026
Health care providers' perceptions of screening for risk of type 1 diabetes in newborns using genetic risk scores.
Article in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To explore health care providers’ perceptions of using polygenic risk scores (PRS) to screen newborns for the risk of developing type 1 diabetes (T1D) prior to its implementation in Early Check, an expanded newborn screening program in North Carolina (NC), an online survey was conducted with pediatric providers in NC followed by interviews with a subset of providers who responded to the survey. Forty-eight providers completed the survey, and 14 participated in an interview. Participants identified improved health outcomes, provider decision-making, and parental decision-making as the primary potential benefits of screening for risk of T1D. Increased parental anxiety, insufficient provider knowledge, and out-of-pocket expenses for families were described as significant potential barriers. Participants requested tools for educating parents on screening and results, guidelines for follow-up and when to refer to a specialist, and access to a genetic counselor for questions. Participants were generally supportive of screening for T1D risk using PRS, though barriers need to be addressed to optimize the practice for widespread clinical use. This study fills a gap in the literature related to providers’ attitudes and perspectives on screening for T1D using PRS in newborns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.